1. Part 2: Deregulated Expressions of PIWI Proteins and piRNAs as New Candidate Biomarkers and Potential Therapeutic Tools in Cancer
   Didier Meseure et al, 2020, Chromatin and Epigenetics CrossRef
2. 4-Hydroxycoumarin Effects on Both Cellular and Genetic Characteristics of Hepatocellular Carcinoma Cells
   Çağri Öner et al, 2022, Cytology and Genetics CrossRef
3. RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality?
   Kurt Sartorius et al, 2022, Frontiers in Oncology CrossRef
4. Function of the Long Noncoding RNAs in Hepatocellular Carcinoma: Classification, Molecular Mechanisms, and Significant Therapeutic Potentials
   Ahmad Khan et al, 2022, Bioengineering CrossRef
5. Mechanisms of hepatocellular carcinoma progression
   Olorunseun O Ogunwobi et al, 2019, World Journal of Gastroenterology CrossRef
6. Biopathological Significance of PIWI–piRNA Pathway Deregulation in Invasive Breast Carcinomas
   Didier Meseure et al, 2020, Cancers CrossRef
7. Involvement of cytochrome P450 enzymes in inflammation and cancer: a review
   Maria Carolina Stipp et al, 2021, Cancer Chemotherapy and Pharmacology CrossRef
8. Long non-coding RNA HCP5 functions as a sponge of miR-29b-3p and promotes cell growth and metastasis in hepatocellular carcinoma through upregulating DNMT3A
   Yongping Zhou et al, 2021, Aging CrossRef
9. MiR-22 Deficiency Fosters Hepatocellular Carcinoma Development in Fatty Liver
   Monika Gjorgjieva et al, 2022, Cells CrossRef